Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AMRX – Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.
AMRX
$7.83
Name : Amneal Pharmaceuticals, Inc.
Sector : Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Mark. Cap: $2,454,078,464.00
EPSttm : -0.04
finviz dynamic chart for AMRX
Amneal Pharmaceuticals, Inc.
$7.83
0.13%
$0.01

Float Short %

3.76

Margin Of Safety %

24

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.02

EPS Last/This Y

1.09

EPS This/Next Y

0.11

Price

7.83

Target Price

11.75

Analyst Recom

1

Performance Q

1.16

Relative Volume

0.88

Beta

1.12

Ticker: AMRX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04AMRX8.420.090.009231
2025-07-07AMRX8.40.090.009233
2025-07-08AMRX8.250.090.009276
2025-07-09AMRX8.340.090.009269
2025-07-10AMRX8.40.090.009269
2025-07-11AMRX8.320.090.009272
2025-07-14AMRX8.410.090.009273
2025-07-15AMRX8.270.090.009271
2025-07-16AMRX8.270.090.009271
2025-07-17AMRX8.240.080.009492
2025-07-18AMRX7.970.080.109488
2025-07-21AMRX7.910.082.509431
2025-07-22AMRX7.950.090.029471
2025-07-23AMRX8.080.091.259423
2025-07-24AMRX80.090.009751
2025-07-25AMRX8.060.090.009799
2025-07-28AMRX8.180.090.009802
2025-07-29AMRX8.090.097.009818
2025-07-30AMRX8.070.0910.009826
2025-07-31AMRX7.820.090.009835
2025-08-01AMRX7.820.090.209854
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04AMRX8.426.2- 0.70
2025-07-07AMRX8.416.2- 0.70
2025-07-08AMRX8.256.2- 0.70
2025-07-09AMRX8.336.2- 0.70
2025-07-10AMRX8.396.2- 0.70
2025-07-11AMRX8.336.2- 0.70
2025-07-14AMRX8.416.2- 0.70
2025-07-15AMRX8.276.2- 0.70
2025-07-16AMRX8.276.2- 0.70
2025-07-17AMRX8.246.2- 0.70
2025-07-18AMRX7.986.2- 0.70
2025-07-21AMRX7.926.2- 0.70
2025-07-22AMRX7.956.2- 0.70
2025-07-23AMRX8.076.2- 0.70
2025-07-24AMRX8.006.2- 0.70
2025-07-25AMRX8.066.2- 0.70
2025-07-28AMRX8.156.2- 0.70
2025-07-29AMRX8.099.3- 0.71
2025-07-30AMRX8.079.3- 0.71
2025-07-31AMRX7.829.3- 0.71
2025-08-01AMRX7.839.3- 0.71
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04AMRX-3.407.603.73
2025-07-07AMRX-3.397.613.73
2025-07-08AMRX-3.397.613.73
2025-07-09AMRX-3.397.613.73
2025-07-10AMRX-3.397.613.73
2025-07-11AMRX-3.367.614.56
2025-07-14AMRX-3.367.694.56
2025-07-15AMRX-3.367.694.56
2025-07-16AMRX-3.367.694.56
2025-07-17AMRX-3.367.694.56
2025-07-18AMRX-3.367.694.56
2025-07-21AMRX-3.367.714.56
2025-07-22AMRX-3.367.714.56
2025-07-23AMRX-3.367.714.56
2025-07-24AMRX-3.367.714.56
2025-07-25AMRX-3.367.713.76
2025-07-28AMRX-3.366.353.76
2025-07-29AMRX-3.366.353.76
2025-07-30AMRX-3.366.353.76
2025-07-31AMRX-3.366.353.76
2025-08-01AMRX-3.366.353.76
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.19

Avg. EPS Est. Current Quarter

0.17

Avg. EPS Est. Next Quarter

0.17

Insider Transactions

-3.36

Institutional Transactions

6.35

Beta

1.12

Average Sales Estimate Current Quarter

753

Average Sales Estimate Next Quarter

779

Fair Value

9.73

Quality Score

54

Growth Score

82

Sentiment Score

59

Actual DrawDown %

17.4

Max Drawdown 5-Year %

-82.8

Target Price

11.75

P/E

Forward P/E

9.49

PEG

P/S

0.87

P/B

P/Free Cash Flow

10.12

EPS

-0.04

Average EPS Est. Cur. Y​

0.71

EPS Next Y. (Est.)

0.82

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-0.46

Relative Volume

0.88

Return on Equity vs Sector %

-13.8

Return on Equity vs Industry %

2.1

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

Amneal Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 8300
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and distributes pharmaceutical products with focus on central nervous system disorders, including Parkinson's disease, and endocrine disorders. This segment provides Rytary, an oral capsule formulation of carbidopa-levodopa to treat Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism; Unithroid and ONGENTYS for the treatment of hypothyroidism; and CREXONT which is use for the treatment of Parkinson's disease. The AvKARE segment offers pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional customers. It sells its products through wholesalers, distributors, retail pharmacies, managed care organizations, purchasing co-ops, hospitals, government agencies, institutions, and pharmaceutical companies. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
stock quote shares AMRX – Amneal Pharmaceuticals, Inc. Stock Price stock today
news today AMRX – Amneal Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRX – Amneal Pharmaceuticals, Inc. yahoo finance google finance
stock history AMRX – Amneal Pharmaceuticals, Inc. invest stock market
stock prices AMRX premarket after hours
ticker AMRX fair value insiders trading